Caitlin Cronin
Stock Analyst at Canaccord Genuity
(3.90)
# 614
Out of 5,148 analysts
48
Total ratings
50%
Success rate
13.21%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Caitlin Cronin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ESTA Establishment Labs Holdings | Maintains: Buy | $85 → $90 | $76.10 | +18.27% | 4 | Feb 26, 2026 | |
| GMED Globus Medical | Maintains: Buy | $105 → $112 | $93.80 | +19.40% | 3 | Jan 9, 2026 | |
| ENOV Enovis | Maintains: Buy | $58 → $50 | $25.70 | +94.55% | 4 | Dec 17, 2025 | |
| INMD InMode | Maintains: Hold | $16 → $15 | $13.64 | +9.97% | 6 | Dec 17, 2025 | |
| AXGN Axogen | Maintains: Buy | $27 → $37 | $30.65 | +20.72% | 8 | Dec 5, 2025 | |
| TELA TELA Bio | Maintains: Buy | $7 → $4 | $0.86 | +364.74% | 5 | Nov 18, 2025 | |
| SNN Smith & Nephew | Maintains: Hold | $36 → $34 | $35.76 | -4.92% | 4 | Nov 11, 2025 | |
| ATEC Alphatec Holdings | Maintains: Buy | $20 → $25 | $13.47 | +85.60% | 5 | Oct 31, 2025 | |
| VCEL Vericel | Maintains: Buy | $61 → $58 | $35.36 | +64.03% | 4 | Aug 1, 2025 | |
| BVS Bioventus | Maintains: Buy | $15 | $8.77 | +71.04% | 1 | Mar 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $4 | $4.87 | -17.86% | 2 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | $130 | $99.49 | +30.67% | 1 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $270 → $12 | $1.92 | +525.00% | 1 | Nov 14, 2023 |
Establishment Labs Holdings
Feb 26, 2026
Maintains: Buy
Price Target: $85 → $90
Current: $76.10
Upside: +18.27%
Globus Medical
Jan 9, 2026
Maintains: Buy
Price Target: $105 → $112
Current: $93.80
Upside: +19.40%
Enovis
Dec 17, 2025
Maintains: Buy
Price Target: $58 → $50
Current: $25.70
Upside: +94.55%
InMode
Dec 17, 2025
Maintains: Hold
Price Target: $16 → $15
Current: $13.64
Upside: +9.97%
Axogen
Dec 5, 2025
Maintains: Buy
Price Target: $27 → $37
Current: $30.65
Upside: +20.72%
TELA Bio
Nov 18, 2025
Maintains: Buy
Price Target: $7 → $4
Current: $0.86
Upside: +364.74%
Smith & Nephew
Nov 11, 2025
Maintains: Hold
Price Target: $36 → $34
Current: $35.76
Upside: -4.92%
Alphatec Holdings
Oct 31, 2025
Maintains: Buy
Price Target: $20 → $25
Current: $13.47
Upside: +85.60%
Vericel
Aug 1, 2025
Maintains: Buy
Price Target: $61 → $58
Current: $35.36
Upside: +64.03%
Bioventus
Mar 17, 2025
Maintains: Buy
Price Target: $15
Current: $8.77
Upside: +71.04%
Nov 14, 2024
Maintains: Buy
Price Target: $3 → $4
Current: $4.87
Upside: -17.86%
Feb 23, 2024
Reiterates: Hold
Price Target: $130
Current: $99.49
Upside: +30.67%
Nov 14, 2023
Downgrades: Hold
Price Target: $270 → $12
Current: $1.92
Upside: +525.00%